D-Actor 200

Company: CuraMedix

Address: 701 George Washington Hwy. Suite 300 Lincoln, RI 02865

Phone: 877-699-8399

Web site: http://www.curamedix.com

Description: D-Actor 200 from CuraMedix features extracorporeal pulse activation technology (EPAT) and is marketed as the first high frequency pain management system with a broad range of applications. EPAT is proprietary technology based on several unique sets of acoustic pressure waves that activate biologic and angiogenic responses including new vascularization and microcirculatory improvement, helping to restore the body€™s normal healing processes and tissue regeneration. EPAT acoustic pressure waves combine compressive and tensile stresses on cells and structures to promote an inflammatory response in musculoskeletal and soft tissue, resulting in microcirculatory improvement, including the proliferation of angiogenic growth factors, enhanced new blood vessel formation (angiogenesis) and subsequent regeneration of tissue allowing the body€™s own healing response to reinitiate or be enhanced. For a patient with musculoskeletal disorders, this can represent a fast-track to resuming normal activities without the risks, side effects, downtime, or costs of traditional treatment methods including surgery.

Features:

• Broad range fast, safe, of non-invasive applications
• No anesthetics required forshortened recovery
• Low capital expenditure and maintenance costs
• Ergonomic compact design for maximum mobility
• Improved patient outcomes with short treatment sessions
• Improved practice efficiencies and increased referrals